the possibility that inhibition by anti-cd8 mab resulted for competition for the fcr between the anti-cd3 mab and anti-cd8 mab was eliminated by targeting tnp-modified cells with an antibody heteroconjugate prepared from fab fragments of anti-cd3 and anti-dnp antibodies .
C0003250
mab
C0003241
antibody